Cargando…
Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?
More than 1,200 active or recruiting clinical trials for novel coronavirus disease 2019 (COVID-19) treatments and vaccines are registered. Many drugs have shown promise for treatment of COVID-19. Nevertheless, up to date, no drugs have been confirmed as a definitive treatment for COVID-19. Trials su...
Autores principales: | Zaitoun, Mohamed M. A., Basha, Mohammad Abd Alkhalik, Elmokadem, Ali Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338094/ https://www.ncbi.nlm.nih.gov/pubmed/32632766 http://dx.doi.org/10.1186/s41747-020-00171-4 |
Ejemplares similares
-
"Bronchial Artery Delivery of Viral Vectors for Gene delivery in Cystic Fibrosis; Superior to Airway Delivery?"
por: Bakhai, Ameet, et al.
Publicado: (2002) -
Ambroxol for the treatment of fibromyalgia: science or fiction?
por: Kern, Kai-Uwe, et al.
Publicado: (2017) -
Splenectomy for hypersplenism with or without preoperative splenic artery embolisation
por: Zaitoun, Mohamed M. A., et al.
Publicado: (2018) -
The enigma of soluble LDLR: could inflammation be the key?
por: Mbikay, Majambu, et al.
Publicado: (2020) -
Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes
por: Zaitoun, Mohamed M. A., et al.
Publicado: (2021)